THE FABRICATION OF MIP BASED ELECTROCHEMICAL SENSOR FOR THE DETERMINATION OF DOBUTAMINE
-
Published:2024-08-14
Issue:3
Volume:48
Page:31-31
-
ISSN:1015-3918
-
Container-title:Ankara Universitesi Eczacilik Fakultesi Dergisi
-
language:en
-
Short-container-title:Ankara Ecz. Fak. Derg.
Author:
Özçelikay Akyıldız Göksu1ORCID, Kaya Sariye İrem2ORCID
Affiliation:
1. ANKARA UNIVERSITY, FACULTY OF PHARMACY 2. Sağlık Bilimleri Üniversitesi, Gülhane Eczacılık Fakültesi, Analik Kimya Anabilim Dalı, 06018, Ankara, Türkiye
Abstract
Objective: Dobutamine (DBT), one of the most common synthetic catecholamines, is important in the renal, cardiovascular, hormonal, and central nervous systems. In our study, it is proposed to produce the first MIP-based electrochemical sensor for DBT analysis. MIP(DBT)/GCE was developed by electropolymerization of 4-aminobenzoic acid (4-ABA) in the presence of DBT. Analytical performance and validation evaluation were performed on both standard solution and commercial serum samples.
Material and Method: DBT was supplied by the Vem pharmaceutical company. For the preparation of 5 mM [Fe(CN)6]3-/4- solution, known amounts of potassium ferricyanide ([K3Fe(CN)6]) and potassium ferrocyanide (K4[Fe(CN)6].3H2O mixed in 0.1 M KCl solution. The 4-ABA was used to create the polymeric film in the presence of DBT. Electrochemical measurements were actualized in IVIUM compactStat.h potentiostat (Eindhoven, The Netherlands) using a three-electrode system consisting of Pt wire, Ag/AgCl reference electrode, and glassy carbon electrode (GCE).
Result and Discussion: The MIP(DBT)/GCE sensor was applied to standard solution and commercial serum samples. When DBT concentrations were plotted against ΔI values, a linear response between 1×10-13 and 1×10-12 M was obtained in both environments. LOD results were found to be 0.087×10-13 M and 0.033×10-13 M in standard solution and commercial human serum, respectively. Recovery% and RSD% were found to be 99.68-100.32% and 1.38-1.66%, respectively.
Publisher
Ankara Universitesi Eczacilik Fakultesi Dergisi
Reference22 articles.
1. 1. Takkis, K., Veigure, R., Metsvaht, T., Hallik, M., Ilmoja, M.L., Starkopf, J., Kipper, K. (2019). A sensitive method for the simultaneous UHPLC-MS/MS analysis of milrinone and dobutamine in blood plasma using NH4F as the eluent additive and ascorbic acid as a stabilizer. Clinical Mass Spectrometry, 12, 23-29. [CrossRef] 2. 2. Long, Z., Zhan, Z., Guo, Z., Li, Y., Yao, J., Ji, F., Li, C., Zheng, X., Ren, B., Huang, T. (2019). A novel two-dimensional liquid chromatography - Mass spectrometry method for direct drug impurity identification from HPLC eluent containing ion-pairing reagent in mobile phases. Analytical Chemistry Acta, 1049, 105-114. [CrossRef] 3. 3. Albóniga, O.E., Alonso, M.L., Blanco, M.E., González, O., Grisaleña, A., Campanero, M.A., Alonso, R.M. (2017). Quantitative determination of dobutamine in newborn pig plasma samples by HPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis, 145, 178-185. [CrossRef] 4. 4. Thippani, R., Pothuraju, N.R., Ramisetti, N.R., Shaik, S. (2013). Optimization and validation of a fast RP-HPLC method for the determination of dobutamine in rat plasma: Pharmacokinetic studies in healthy rat subjects. Journal of Pharmaceutical Analysis, 3(6), 434-439. [CrossRef] 5. 5. Meineke, I., Steinmetz, H., Kramer, S., Gleiter, C.H. (2002). Determination of fenoterol in human plasma by HPLC with fluorescence detection after derivatization. Journal of Pharmaceutical and Biomedical Analysis, 29, (1-2), 147-152. [CrossRef]
|
|